Farms.com Home   News

Exports Account For More Than 50 Percent Of U.S. Cotton And Almond Production

Exports play a significant role for U.S. agricultural producers. For many commodities, exports make up a sizeable share of the market for U.S. production. In the case of cotton and almonds, the United States sends more of its product abroad than is consumed domestically. Roughly 75 percent of all U.S. cotton is exported, with the majority going to countries in North and Central America like Canada, Mexico, and Nicaragua. U.S.-produced almonds, grown almost exclusively in California, represent nearly 79 percent of global supply and are naturally shipped worldwide, with 67 percent of production exported. Rice, soybeans, and wheat also depend heavily on export markets as the destination for about half of domestic supply. The wealth of cropland throughout the Midwest and other parts of America gives domestic suppliers the capacity to scale production beyond the needs of the U.S. market, allowing agriculture’s share of the U.S. economy to grow. This chart appears in the ERS publication Selected charts from Ag and Food Statistics: Charting the Essentials, 2017, released April 28, 2017.
 

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.